Rosacea Treatment Market Report by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Ot

Rosacea Treatment Market Report by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others), Route of Administration (Topical, Oral), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2024-2032


The global rosacea treatment market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032.

Rosacea treatment refers to preventive measures adopted to cure a chronic skin disease that enlarges blood vessels and causes redness. It includes oral and topical medications, such as antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents. In severe cases, intense pulsed light therapy, laser treatment, and cosmetic surgery are used to remove thickened skin, shrink tissues, and treat rhinophyma. Rosacea treatment assists in easing the symptoms, such as skin inflammation, redness, inflamed eyes, and puss-filled bumps that generally occur on the nose, cheeks, chest, ear, back, and forehead. It also reduces skin discoloration and improves dryness, itching, blurred vision, and sensitivity to light.

Rosacea Treatment Market Trends:
The increasing prevalence of rosacea due to excessive temperature changes, exercise, rising application of cosmetics, pharmaceuticals, and widespread consumption of spicy meals, hot drinks, and alcohol is one of the key factors driving the market growth. Furthermore, increasing demand for oral treatments, such as syrups, tablets, capsules, and liquids, to reduce redness, acne, pimples, and bacterial inflammation, is providing a considerable boost to the market growth. Additionally, the introduction of artificial intelligence (AI)-powered diagnostic tools that utilize digital image shots in natural white light and resolutions to identify facial lesions and symptoms and recognize areas prone to rosacea is creating a positive outlook for the market. Moreover, increasing adoption of combination treatments to reduce initial prominent symptoms, prevent relapse on discontinuation of oral therapy, and maintain long-term control is providing an impetus to the market growth. Other factors, including increasing initiatives and investments by several governments to promote research and development (R&D) activities, rising expenditure capacities of consumers, the launch of new generic products by pharmaceutical companies to increase the efficiency of the treatment, and growing awareness of early diagnosis and effective treatment options, are anticipated to drive market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global rosacea treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug class, route of administration, distribution channel and end user.

Breakup by Type:

Erythematotelangiectatic Rosacea
Papulopustular Rosacea
Ocular Rosacea
Phymatous Rosacea

Breakup by Drug Class:

Antibiotics
Alpha Agonists
Retinoids
Corticosteroids
Immunosuppressants
Antihypertensive Agents
Others

Breakup by Route of Administration:

Topical
Oral

Breakup by Distribution Channel:

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others

Breakup by End User:

Hospitals
Homecare
Specialty Clinics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cellix Bio Private Limited, Colorescience Inc., Croda International Plc, Galderma S.A., LEO Pharma A/S, Lupin Limited, Maruho Co. Ltd., PruGen Pharmaceuticals, Sol-Gel Technologies Ltd. and Timber Pharmaceuticals LLC.

Key Questions Answered in This Report

1. What was the size of the global rosacea treatment market in 2023?
2. What is the expected growth rate of the global rosacea treatment market during 2024-2032?
3. What are the key factors driving the global rosacea treatment market?
4. What has been the impact of COVID-19 on the global rosacea treatment market?
5. What is the breakup of the global rosacea treatment market based on the drug class?
6. What is the breakup of the global rosacea treatment market based on the route of administration?
7. What are the key regions in the global rosacea treatment market?
8. Who are the key players/companies in the global rosacea treatment market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Rosacea Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Erythematotelangiectatic Rosacea
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Papulopustular Rosacea
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ocular Rosacea
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Phymatous Rosacea
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Antibiotics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Alpha Agonists
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Retinoids
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Corticosteroids
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Immunosuppressants
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Antihypertensive Agents
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Topical
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Online Pharmacy
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Pharmacy
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Homecare
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Specialty Clinics
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Bausch Health Companies Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Cellix Bio Private Limited
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Colorescience Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Croda International Plc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Galderma S.A.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 LEO Pharma A/S
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 Lupin Limited
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Maruho Co. Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 SWOT Analysis
16.3.9 PruGen Pharmaceuticals
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Sol-Gel Technologies Ltd.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.11 Timber Pharmaceuticals LLC
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings